News

#FixFundraising campaign

26 May 2017

For years the laws that govern fundraising in Australia have grown hopelessly outdated with charities facing heavy amounts of red tape and time-consuming paperwork every way they turn, particularly for national groups. These state-based laws and permits provide little to no protection for the consumer, nor oversight of the sector of fundraising.

Finally, charities have taken a stand. Last year a number of not-for-profits (NFPs) came together to create the #fixfundraising coalition. The coalition called on the Australian government to create a nationally consistent NFP regulatory regime that can be adopted by all charities. In doing so, they released a Statement on Fundraising Reform, which outlined a revised fundraising framework with a three step plan:

  1. Clarification and minor amendments to the Australian Consumer Law (ACL) to ensure application to fundraising activities is clear and broad
  2. Repeal of fragmented, time consuming, state and territory fundraising laws, and
  3. Work with regulators and self-regulatory bodies to provide guidance to fundraisers to continue to improve fundraiser conduct.

The #fixfundraising coalition highlighted that the current local laws are inconsistent, not suited to cross-border activities, digital activities and crowd sourcing, and hinder the work of the not-for-profit sector.

They have written to the Prime Minister along with every Australian head of government calling for governments to prioritise working together to fix this fundraising mess so NFP’s can get on with what they do best – building flourishing communities. Over 150 charities have signed the letter with others still able to sign here.

Some states of Australia, have already made headway in doing away with these rules and permits.

MS Research Australia is passionately in favour of this reform and have added our name to the growing list of supporters.

Useful links:

Related News

MS News

PBAC rapid review of MS medicines: what it means for the MS community

13 August 2026

Further details have now been announced about the Pharmaceutical Benefits Advisory Committee’s rapid review of medicines listed on the Pharmaceutical Benefits Scheme (PBS) for relapsing-remitting multiple sclerosis. 

MS News

Susan Hyde

29 July 2026

Susan reflects on her journey with MS from a young age, her diagnosis story and the importance of building a strong support network.

MS News

Researchers turn to lab-grown ‘mini brains’ in search of ways to repair MS damage

29 July 2026

The research, funded through MS Australia's mid-year grants round and based at The Florey Institute of Neuroscience and Mental Health, will investigate how the brain naturally produces myelin, the protective coating around nerve fibres that is damaged by MS. 

Read More

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

#FixFundraising campaign